-
1
Cannabinoid Hyperemesis
Published 2010-01-01“…Cannabinoid hyperemesis syndrome is characterized by chronic, heavy use of cannabis, recurrent episodes of severe nausea and intractable vomiting, and abdominal pain. …”
Get full text
Article -
2
-
3
Cannabinoids and the endocannabinoid system in liver diseases
Published 2024-12-01Subjects: Get full text
Article -
4
Guidelines for the Use of Cannabinoid Compounds in Chronic Pain
Published 2005-01-01“…OBJECTIVE: To provide clinicians with guidelines for the use of cannabinoid compounds in the treatment of chronic pain.…”
Get full text
Article -
5
Placental Cannabinoid Receptor Expression in Preterm Birth
Published 2024-01-01Get full text
Article -
6
Cannabinoids: A New Group of Agonists of PPARs
Published 2007-01-01“…Cannabinoids have been used medicinally and recreationally for thousands of years and their effects were proposed to occur mainly via activation of the G-protein-coupled receptor CB1/CB2 (cannabinoid receptor 1/2). …”
Get full text
Article -
7
Preclinical Science Regarding Cannabinoids as Analgesics: An Overview
Published 2005-01-01“…Since then, potent antinociceptive and antihyperalgesic effects of cannabinoid agonists in animal models of acute and chronic pain; the presence of cannabinoid receptors in pain-processing areas of the brain, spinal cord and periphery; and evidence supporting endogenous modulation of pain systems by cannabinoids has provided support that cannabinoids exhibit significant potential as analgesics. …”
Get full text
Article -
8
-
9
The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity
Published 2015-01-01“…Even though synthetic cannabinoids have been restricted, they are still readily available across USA and their use has been dramatically increasing, with a concomitant increment in reports to poison control centers and emergency department (ED) visits. …”
Get full text
Article -
10
Commercial Cannabinoid Oil-Induced Stevens-Johnson Syndrome
Published 2020-01-01Get full text
Article -
11
Proceedings of the Inaugural Meeting of the Canadian Consortium for the Investigation of Cannabinoids
Published 2001-01-01Get full text
Article -
12
Safety Issues Concerning the Medical Use of Cannabis and Cannabinoids
Published 2005-01-01“…Standardized, quality-controlled cannabinoid products are available in Canada, and safety profiles of approved medications are available through the Canadian formulary. …”
Get full text
Article -
13
Brugada Phenocopy Type 1 Secondary to Synthetic Cannabinoids
Published 2020-01-01“…We present a very rare case of a young patient who had a Brugada phenocopy Type 1 suspected to be secondary to synthetic cannabinoids.…”
Get full text
Article -
14
Update on the Role of Cannabinoid Receptors after Ischemic Stroke
Published 2012-01-01“…Cannabinoids are considered as key mediators in the pathophysiology of inflammatory diseases, including atherosclerosis. …”
Get full text
Article -
15
Cannabinoids for the Treatment of Pain: An Update on Recent Clinical Trials
Published 2005-01-01“…Over the past five years, there has been a considerable increase in clinical research on cannabinoid use for a range of pain syndromes. Cannabinoid products are becoming available for research and clinical use, and pharmaceutical industry interest in the potential for cannabinoids in therapeutics is also gaining momentum. …”
Get full text
Article -
16
Neuroprotective Actions of Cannabinoids in the Bovine Isolated Retina: Role of Hydrogen Sulfide
Published 2025-01-01Subjects: Get full text
Article -
17
Muscarinic cannabinoid suppression of excitation, a novel form of coincidence detection
Published 2025-02-01“…We refer to this inhibition as muscarinic cannabinoid suppression of excitation (MCSE). MCSE can be mimicked by coapplication of muscarinic and cannabinoid agonists and requires Ca2+-release from internal stores. …”
Get full text
Article -
18
A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria
Published 2019-01-01“…Recreational use of synthetic cannabinoids (SCs), also known as “K2” or “Spice,” is becoming a major public-health concern due to their potential for abuse and harmful consequences. …”
Get full text
Article -
19
Editorial: Cognitive stimulants: from caffeine to cannabinoids - current and future perspectives
Published 2025-01-01Get full text
Article -
20
Cannabinoid receptor 2 facilitates the Schwann cells‐dependent peripheral nerve regeneration
Published 2025-01-01Get full text
Article